CDKN2A and cancer: Increased p16 expression has been observed in cancer samples of cervix [48], penis [49], head and neck [50], oral [51] and the anorectal region [52] when positive for high-risk HPVs and its overexpression was found to be a reliable marker for high-risk HPV in penile carcinoma [53].